Selected research
Industry Research
Sartans Industry Research Report 2026
Market perspective
The global Sartans market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sartans is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sartans is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sartans is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sartans include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sartans market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sartans Market by Company
Teva Pharmaceutical
Sanofi
Jhonson and Johnson
Novartis
Merck
Eli Lilly
Pfizer
GSK
Bayer
Bristol-Myers Squibb
Astra Zeneca
Sartans Segment by Type
Valsartan
Telmisartan
Losartan
Irbesartan
Olmesartan
Azilsartan
Sartans Segment by Application
Cardiovascular Diseases
Kidney Diseases
Hypertension
Other
Sartans Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sartans market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sartans and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sartans.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sartans manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sartans by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sartans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Valsartan
- Telmisartan
- Losartan
- Irbesartan
- Olmesartan
- Azilsartan
Applications
- Cardiovascular Diseases
- Kidney Diseases
- Hypertension
- Other
Companies covered
- Teva Pharmaceutical
- Sanofi
- Jhonson and Johnson
- Novartis
- Merck
- Eli Lilly
- Pfizer
- GSK
- Bayer
- Bristol-Myers Squibb
- Astra Zeneca
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sartans Market Size (2021-2032)
- 2.2.2 Global Sartans Sales (2021-2032)
- 2.2.3 Global Sartans Market Average Price (2021-2032)
- 2.3 Sartans by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Valsartan
- 2.3.3 Telmisartan
- 2.3.4 Losartan
- 2.3.5 Irbesartan
- 2.3.6 Olmesartan
- 2.3.7 Azilsartan
- 2.4 Sartans by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cardiovascular Diseases
- 2.4.3 Kidney Diseases
- 2.4.4 Hypertension
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sartans Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sartans Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Sartans Revenue of Manufacturers (2021-2026)
- 3.4 Global Sartans Average Price by Manufacturers (2021-2026)
- 3.5 Global Sartans Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sartans, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sartans, Product Type & Application
- 3.8 Global Manufacturers of Sartans, Established Date
- 3.9 Global Sartans Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Sartans Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Sartans Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Jhonson and Johnson
- 4.3.1 Jhonson and Johnson Company Information
- 4.3.2 Jhonson and Johnson Business Overview
- 4.3.3 Jhonson and Johnson Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jhonson and Johnson Sartans Product Portfolio
- 4.3.5 Jhonson and Johnson Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Sartans Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Sartans Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Company Information
- 4.6.2 Eli Lilly Business Overview
- 4.6.3 Eli Lilly Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eli Lilly Sartans Product Portfolio
- 4.6.5 Eli Lilly Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Sartans Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 GSK
- 4.8.1 GSK Company Information
- 4.8.2 GSK Business Overview
- 4.8.3 GSK Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GSK Sartans Product Portfolio
- 4.8.5 GSK Recent Developments
- 4.9 Bayer
- 4.9.1 Bayer Company Information
- 4.9.2 Bayer Business Overview
- 4.9.3 Bayer Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bayer Sartans Product Portfolio
- 4.9.5 Bayer Recent Developments
- 4.10 Bristol-Myers Squibb
- 4.10.1 Bristol-Myers Squibb Company Information
- 4.10.2 Bristol-Myers Squibb Business Overview
- 4.10.3 Bristol-Myers Squibb Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol-Myers Squibb Sartans Product Portfolio
- 4.10.5 Bristol-Myers Squibb Recent Developments
- 4.11 Astra Zeneca
- 4.11.1 Astra Zeneca Company Information
- 4.11.2 Astra Zeneca Business Overview
- 4.11.3 Astra Zeneca Sartans Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Astra Zeneca Sartans Product Portfolio
- 4.11.5 Astra Zeneca Recent Developments
5 Global Sartans Market Scenario by Region
- 5.1 Global Sartans Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sartans Sales by Region: 2021-2032
- 5.2.1 Global Sartans Sales by Region: 2021-2026
- 5.2.2 Global Sartans Sales by Region: 2027-2032
- 5.3 Global Sartans Revenue by Region: 2021-2032
- 5.3.1 Global Sartans Revenue by Region: 2021-2026
- 5.3.2 Global Sartans Revenue by Region: 2027-2032
- 5.4 North America Sartans Market Facts & Figures by Country
- 5.4.1 North America Sartans Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sartans Sales by Country (2021-2032)
- 5.4.3 North America Sartans Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sartans Market Facts & Figures by Country
- 5.5.1 Europe Sartans Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sartans Sales by Country (2021-2032)
- 5.5.3 Europe Sartans Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sartans Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sartans Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sartans Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sartans Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sartans Market Facts & Figures by Country
- 5.7.1 South America Sartans Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sartans Sales by Country (2021-2032)
- 5.7.3 South America Sartans Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sartans Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sartans Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sartans Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sartans Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sartans Sales by Type (2021-2032)
- 6.1.1 Global Sartans Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Sartans Sales Market Share by Type (2021-2032)
- 6.2 Global Sartans Revenue by Type (2021-2032)
- 6.2.1 Global Sartans Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sartans Revenue Market Share by Type (2021-2032)
- 6.3 Global Sartans Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sartans Sales by Application (2021-2032)
- 7.1.1 Global Sartans Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Sartans Sales Market Share by Application (2021-2032)
- 7.2 Global Sartans Revenue by Application (2021-2032)
- 7.2.1 Global Sartans Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sartans Revenue Market Share by Application (2021-2032)
- 7.3 Global Sartans Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sartans Value Chain Analysis
- 8.1.1 Sartans Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sartans Production Mode & Process
- 8.2 Sartans Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sartans Distributors
- 8.2.3 Sartans Customers
9 Global Sartans Analyzing Market Dynamics
- 9.1 Sartans Industry Trends
- 9.2 Sartans Industry Drivers
- 9.3 Sartans Industry Opportunities and Challenges
- 9.4 Sartans Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst